Octogenarian newly diagnosed multiple myeloma patients without geriatric impairments: the role of age >80 in the IMWG frailty score

被引：10

作者：

D'Agostino, Mattia ^{[1
]}

Larocca, Alessandra ^{[1
]}

Offidani, Massimo ^{[2
]}

Liberati, Anna Marina ^{[3
]}

Gaidano, Gianluca ^{[4
]}

Petrucci, Maria Teresa ^{[5
]}

Derudas, Daniele ^{[6
]}

Capra, Andrea ^{[1
]}

Zambello, Renato ^{[7
]}

Cascavilla, Nicola ^{[8
]}

de Fabritiis, Paolo ^{[9
]}

Innao, Vanessa ^{[10
]}

Bonello, Francesca ^{[1
]}

Patriarca, Francesca ^{[11
,12
]}

Benevolo, Giulia ^{[13
]}

Giuliani, Nicola ^{[14
,15
]}

Aitoro, Gabriele ^{[16
,17
,18
]}

Guglielmelli, Tommasina ^{[19
]}

Di Raimondo, Francesco ^{[20
]}

Corradini, Paolo ^{[21
]}

Musto, Pellegrino ^{[22
,23
]}

Hajek, Roman ^{[24
,25
]}

Sonneveld, Pieter ^{[26
]}

Boccadoro, Mario ^{[1
]}

Bringhen, Sara ^{[1
]}

机构：

[1] Univ Torino, Div Hematol, Myeloma Unit, Azienda Osped Univ Citta Salute & Sci Torino, Turin, Italy

[2] AOU Osped Riuniti Ancona, Clin Ematol, Ancona, Italy

[3] Univ Perugia, Azienda Osped Santa Maria, Terni, Italy

[4] Univ Piemonte Orientale, Div Hematol, Dept Translat Med, I-28100 Novara, Italy

[5] Sapienza Univ Rome, Dept Translat & Precis Med, Azienda Osped Policlin Umberto I, Hematol, Rome, Italy

[6] Osped Oncol Riferimento Reg A Businco, SC Ematol & CTMO, ARNAS G Brozu, Cagliari, Italy

[7] Padova Univ, Sch Med Hematol & Clin Immunol, Padua, Italy

[8] IRCCS Casa Sollievo Sofferenza, Div Hematol, San Giovanni Rotondo, Italy

[9] Tor Vergata Univ, St Eugenio Hosp ASL Roma 2, Hematol, Rome, Italy

[10] Univ Messina, Dept Human Pathol Adulthood & Childhood, Div Hematol, I-98122 Messina, Italy

[11] Univ Udine, Clin Ematol, Azienda Sanit Univ Friuli Cent ASUFC, Dipartimento Area Med DAME, Udine, Italy

[12] Univ Udine, Unita Terapie Cellulari, Azienda Sanit Univ Friuli Cent ASUFC, Dipartimento Area Med DAME, Udine, Italy

[13] AO Citta Salute & Sci, SC Hematol, Turin, Italy

[14] Univ Parma, Azienda Osped Univ, Hematol, Parma, Italy

[15] Univ Parma, Dept Med & Surg, Parma, Italy

[16] Azienda Sanit Locale Torino 4, Dept Med, Cirie, Italy

[17] Azienda Sanit Locale Torino 4, Dept Med, Chivasso, Italy

[18] Azienda Sanit Locale Torino 4, Dept Med, Ivrea, Italy

[19] Osped San Luigi Gonzaga, Ematol, Orbassano, Italy

[20] Univ Catania, AOU Policlin, Div Hematol, Catania, Italy

[21] Univ Milan, Div Ematol, Fdn IRCCS Ist Nazl Tumori Milano, Milan, Italy

[22] Aldo Moro Univ, Dept Emergency & Organ Transplantat, Sch Med, Bari, Italy

[23] AOUC Policlin, Unit Hematol & Stem Cell Transplantat, Bari, Italy

[24] Univ Hosp Ostrava, Dept Haematooncol, Ostrava, Czech Republic

[25] Univ Ostrava, Fac Med, Ostrava, Czech Republic

[26] Erasmus MC Canc Inst, Dept Hematol, Rotterdam, Netherlands

来源：

BLOOD CANCER JOURNAL | 2021年 / 11卷 / 04期

关键词：

BORTEZOMIB;

D O I：

10.1038/s41408-021-00464-w

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页数：5

共 11 条

[1] Lenalidomide-based induction and maintenance in elderly newly diagnosed multiple myeloma patients: updated results of the EMN01 randomized trial [J].

Bringhen, Sara ;

D'Agostino, Mattia ;

Paris, Laura ;

Ballanti, Stelvio ;

Pescosta, Norbert ;

Spada, Stefano ;

Pezzatti, Sara ;

Grasso, Mariella ;

Rota-Scalabrini, Delia ;

De Rosa, Luca ;

Pavone, Vincenzo ;

Gazzera, Giulia ;

Aquino, Sara ;

Poggiu, Marco ;

Santoro, Armando ;

Gentile, Massimo ;

Baldini, Luca ;

Petrucci, Maria Teresa ;

Tosi, Patrizia ;

Marasca, Roberto ;

Cellini, Claudia ;

Palumbo, Antonio ;

Falco, Patrizia ;

Hajek, Roman ;

Boccadoro, Mario ;

Larocca, Alessandra .

HAEMATOLOGICA, 2020, 105 (07) :1937-1947

[2] Early mortality in myeloma patients treated with first-generation novel agents thalidomide, lenalidomide, bortezomib at diagnosis: A pooled analysis [J].

Bringhen, Sara ;

Offidani, Massimo ;

Palmieri, Salvatore ;

Pisani, Francesco ;

Rizzi, Rita ;

Spada, Stefano ;

Evangelista, Andrea ;

Di Renzo, Nicola ;

Musto, Pellegrino ;

Marcatti, Magda ;

Vallone, Roberto ;

Storti, Sergio ;

Bernardini, Annalisa ;

Centurioni, Riccardo ;

Aitini, Enrico ;

Palmas, Angelo ;

Annibali, Ombretta ;

Angelucci, Emanuele ;

Ferrando, Paola ;

Baraldi, Anna ;

Rocco, Stefano ;

Andriani, Alessandro ;

Siniscalchi, Agostina ;

De Stefano, Valerio ;

Meneghini, Vittorio ;

Palumbo, Antonio ;

Grammatico, Sara ;

Boccadoro, Mario ;

Larocca, Alessandra .

CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2018, 130 :27-35

[3] Carfilzomib, cyclophosphamide, and dexamethasone in patients with newly diagnosed multiple myeloma: a multicenter, phase 2 study [J].

Bringhen, Sara ;

Petrucci, Maria Teresa ;

Larocca, Alessandra ;

Conticello, Concetta ;

Rossi, Davide ;

Magarotto, Valeria ;

Musto, Pellegrino ;

Boccadifuoco, Luana ;

Offidani, Massimo ;

Omede, Paola ;

Gentilini, Fabiana ;

Ciccone, Giovannino ;

Benevolo, Giulia ;

Genuardi, Mariella ;

Montefusco, Vittorio ;

Oliva, Stefania ;

Caravita, Tommaso ;

Tacchetti, Paola ;

Boccadoro, Mario ;

Sonneveld, Pieter ;

Palumbo, Antonio .

BLOOD, 2014, 124 (01) :63-69

[4] A phase 2 study of three low-dose intensity subcutaneous bortezomib regimens in elderly frail patients with untreated multiple myeloma [J].

Larocca, A. ;

Bringhen, S. ;

Petrucci, M. T. ;

Oliva, S. ;

Falcone, A. P. ;

Caravita, T. ;

Villani, O. ;

Benevolo, G. ;

Liberati, A. M. ;

Morabito, F. ;

Montefusco, V. ;

Passera, R. ;

De Rosa, L. ;

Omede, P. ;

Vincelli, I. D. ;

Spada, S. ;

Carella, A. M. ;

Ponticelli, E. ;

Derudas, D. ;

Genuardi, M. ;

Guglielmelli, T. ;

Nozzoli, C. ;

Aghemo, E. ;

De Paoli, L. ;

Conticello, C. ;

Musolino, C. ;

Offidani, M. ;

Boccadoro, M. ;

Sonneveld, P. ;

Palumbo, A. .

LEUKEMIA, 2016, 30 (06) :1320-1326

[5] Dose/schedule-adjusted Rd-R vs continuous Rd for elderly, intermediate-fit patients with newly diagnosed multiple myeloma [J].

Larocca, Alessandra ;

Bonello, Francesca ;

Gaidano, Gianluca ;

D'Agostino, Mattia ;

Offidani, Massimo ;

Cascavilla, Nicola ;

Capra, Andrea ;

Benevolo, Giulia ;

Tosi, Patrizia ;

Galli, Monica ;

Marasca, Roberto ;

Giuliani, Nicola ;

Bernardini, Annalisa ;

Antonioli, Elisabetta ;

Rota-Scalabrini, Delia ;

Cellini, Claudia ;

Pompa, Alessandra ;

Monaco, Federico ;

Patriarca, Francesca ;

di Toritto, Tommaso Caravita ;

Corradini, Paolo ;

Tacchetti, Paola ;

Boccadoro, Mario ;

Bringhen, Sara .

BLOOD, 2021, 137 (22) :3027-3036

[6] Patient-centered practice in elderly myeloma patients: an overview and consensus from the European Myeloma Network (EMN) [J].

Larocca, Alessandra ;

Dold, Sandra Maria ;

Zweegman, Sonja ;

Terpos, Evangelos ;

Waesch, Ralph ;

D'Agostino, Mattia ;

Scheubeck, Sophia ;

Goldschmidt, Hartmut ;

Gay, Francesca ;

Cavo, Michele ;

Ludwig, Heinz ;

Straka, Christian ;

Bringhen, Sara ;

Auner, Holger W. ;

Caers, Jo ;

Gramatzki, Martin ;

Offidani, Massimo ;

Dimopoulos, Meletios A. ;

Einsele, Hermann ;

Boccadoro, Mario ;

Sonneveld, Pieter ;

Engelhardt, Monika .

LEUKEMIA, 2018, 32 (08) :1697-1712

[7]

Mina Roberto, 2019, Am Soc Clin Oncol Educ Book, V39, P500, DOI 10.1200/EDBK_239067

[8] Geriatric assessment predicts survival and toxicities in elderly myeloma patients: an International Myeloma Working Group report [J].

Palumbo, Antonio ;

Bringhen, Sara ;

Mateos, Maria-Victoria ;

Larocca, Alessandra ;

Facon, Thierry ;

Kumar, Shaji K. ;

Offidani, Massimo ;

McCarthy, Philip ;

Evangelista, Andrea ;

Lonial, Sagar ;

Zweegman, Sonja ;

Musto, Pellegrino ;

Terpos, Evangelos ;

Belch, Andrew ;

Hajek, Roman ;

Ludwig, Heinz ;

Stewart, A. Keith ;

Moreau, Philippe ;

Anderson, Kenneth ;

Einsele, Hermann ;

Durie, Brian G. M. ;

Dimopoulos, Meletios A. ;

Landgren, Ola ;

San Miguel, Jesus F. ;

Richardson, Paul ;

Sonneveld, Pieter ;

Rajkumar, S. Vincent .

BLOOD, 2015, 125 (13) :2068-2074

[9] Determining treatment intensity in elderly patients with multiple myeloma [J].

Salvini, Marco ;

D'Agostino, Mattia ;

Bonello, Francesca ;

Boccadoro, Mario ;

Bringhen, Sara .

EXPERT REVIEW OF ANTICANCER THERAPY, 2018, 18 (09) :917-930

[10] Efficacy and Tolerability of Ixazomib, Daratumumab and Low Dose Dexamethasone (Ixa Dara dex) in Unfit and Frail Newly Diagnosed Multiple Myeloma (NDMM) Patients; Results of the Interim Efficacy Analysis of the Phase II HOVON 143 Study [J].

Stege, Claudia A. M. ;

Nasserinejad, Kazem ;

van der Spek, Ellen ;

Van Kampen, Roel J. W. ;

Sohne, Maaike ;

Thielen, Noortje ;

Bilgin, Yavuz ;

De Waal, Esther G. M. ;

Ludwig, Inge ;

Leijs, Maria B. L. ;

Kentos, Alain ;

Timmers, Gert Jan ;

de Heer, Koen ;

Westerman, Matthijs ;

Vekemans, Marie Christiane ;

Durdu-Rayman, Nazik ;

van der Burg-de Graauw, Nicole C. H. P. ;

Van de Donk, Niels W. C. J. ;

Sonneveld, Pieter ;

Klein, Saskia K. ;

Levin, Mark-David ;

Zweegman, Sonja .

BLOOD, 2019, 134

← 1 2 →

Octogenarian newly diagnosed multiple myeloma patients without geriatric impairments: the role of age &gt;80 in the IMWG frailty score

Octogenarian newly diagnosed multiple myeloma patients without geriatric impairments: the role of age >80 in the IMWG frailty score